← Open Payments lookup

LUCINDA FAN: Open Payments

NPI 1578232534 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,242 in 130 payments from 18 companies in 2025. Trend: 2023 $1,716 · 2024 $1,757 · 2025 $3,242

Food & beverage: $3,158Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.17$468
ABBVIE INC.25$467
Takeda Pharmaceuticals U.S.A., Inc.14$407
Madrigal Pharmaceuticals13$405
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$309
GENZYME CORPORATION6$258
Celltrion USA Inc.9$194
Lilly USA, LLC5$148
PFIZER INC.7$129
Regeneron Healthcare Solutions, Inc.4$116

Products named: TREMFYA, REZDIFFRA, DUPIXENT, XIFAXAN, ENTYVIO, VEGZELMA, RINVOQ, LINZESS.

Industry payments across CA — which companies pay providers there.